In 2023, Pfizer published research papers successively, reporting the results of randomized clinical trials on the efficacy and safety of PF-06882961 for blood sugar control in patients with type 2 diabetes, the safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06882961 in Japanese adults with type 2 diabetes from a phase 1 clinical trial, and the results of a 12-week randomized, placebo-controlled, dose-escalation phase 2 trial on the tolerability, safety, and pharmacodynamics of PF-06882961 for the treatment of type 2 diabetes
Mechanism of Action In experimental systems, Ipamorelin selectively binds to GHS-R1a receptors located on pituitary somatotroph cells
Avocados have earned their place in the pantheon of 'superfoods.' They're everywheresmashed on toast, blended into smoothies, and sliced over salads
Food Science & Nutrition 13 (7)
For most people, yes, telogen effluvium is reversible, and hair typically returns to normal once your body adjusts to its new baseline